Branch Retinal Vein Occlusion Clinical Trial
Official title:
Feasibility Study of Anti-VEGF Instead of Intraoperative Fan-shaped Photocoagulation in BRVO Combined With Vitreous Hemorrhage
To evaluate the efficacy and safety of Anti-VEGF instead of intraoperative fan-shaped photocoagulation in BRVO combined with vitreous hemorrhage.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02390245 -
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
|
N/A | |
Active, not recruiting |
NCT04120311 -
Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
|
Phase 1 | |
Not yet recruiting |
NCT04601688 -
Branch Retinal Vein Occlusion (BRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.
|
N/A | |
Completed |
NCT01968239 -
Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT
|
Phase 2 | |
Completed |
NCT00612261 -
Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion
|
N/A | |
Completed |
NCT01976338 -
Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)
|
Phase 3 | |
Completed |
NCT01471691 -
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
|
Phase 1/Phase 2 | |
Completed |
NCT01247220 -
REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study
|
Phase 2 | |
Terminated |
NCT00642226 -
Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
|
Phase 3 | |
Terminated |
NCT05127525 -
EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN)
|
Phase 3 | |
Completed |
NCT01599650 -
Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion
|
Phase 3 | |
Active, not recruiting |
NCT04120636 -
Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
|
Phase 1 | |
Recruiting |
NCT01975103 -
Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases
|
Phase 2 | |
Recruiting |
NCT01348633 -
Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye
|
N/A | |
Completed |
NCT04740905 -
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion
|
Phase 3 | |
Recruiting |
NCT02527733 -
Retinal Sensitivity in BRVO After Anti-VEGF Therapy
|
Phase 4 | |
Completed |
NCT01396057 -
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
|
Phase 3 | |
Terminated |
NCT03802630 -
Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion
|
Phase 3 | |
Completed |
NCT02478515 -
Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion
|
Phase 4 | |
Terminated |
NCT01795209 -
Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision
|
Phase 4 |